Literature DB >> 16680592

Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma.

Shinya Uchino1, Shiro Noguchi, Hiroto Yamashita, Hiroyuki Yamashita, Shin Watanabe, Takahiro Ogawa, Akiko Tsuno, Akiko Murakami, Akira Miyauchi.   

Abstract

INTRODUCTION: Familial adenomatous polyposis (FAP) is an inherited autosomal dominant syndrome caused by germline mutations in the adenomatous polyposis coli (APC) gene. Papillary thyroid cancer is one of the extracolonic manifestations of FAP. A characteristic histologic feature of this type of thyroid tumor is the cribriform-morula variant of papillary thyroid carcinoma (CMVPTC).
METHODS: To investigate roles of the APC and beta-catenin genes in the development of CMVPTC, we examined germline and somatic mutations of these genes in a female patient with CMVPTC and FAP. The patient had undergone total colectomy at the age of 19 years and total thyroidectomy at age 25 years.
RESULTS: Numerous tumors were disseminated in both lobes of the thyroid gland, and histopathologic examination revealed typical CMVPTC. DNA was extracted from peripheral blood leukocytes and 12 CMVPTC tumors, and exons 1-15 of the APC gene and exon 3 of the beta-catenin gene were examined. A germline mutation was detected in exon 13 of the APC gene, and this mutation generated a premature stop codon. Six somatic mutations (922delC, 1602delA, 1821delT, 1920delG, 2706del20, 2804insA) were found in the CMVPTC specimens. All mutations were truncating mutations in the N-terminus of the APC protein. Loss of heterozygosity was not observed in the remaining tumor tissues without somatic APC mutations. There were no mutations of the beta-catenin gene in peripheral blood leukocytes or 12 CMVPTC specimens.
CONCLUSIONS: These results suggest that APC mutations play an important role in the development of CMVPTC and occur predominantly in the 5' side of the APC gene between codons 308 and 935.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680592     DOI: 10.1007/s00268-005-0368-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma.

Authors:  J Cameselle-Teijeiro; C Ruiz-Ponte; L Loidi; J Suarez-Peñaranda; J Baltar; M Sobrinho-Simoes
Journal:  Am J Clin Pathol       Date:  2001-04       Impact factor: 2.493

3.  Adenomatous polyposis: an association with carcinoma of the thyroid.

Authors:  R O Plail; H J Bussey; G Glazer; J P Thomson
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

Review 4.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.

Authors:  H R Harach; G T Williams; E D Williams
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

5.  Identification and characterization of the familial adenomatous polyposis coli gene.

Authors:  J Groden; A Thliveris; W Samowitz; M Carlson; L Gelbert; H Albertsen; G Joslyn; J Stevens; L Spirio; M Robertson
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

6.  Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

Authors:  S Olschwang; A Tiret; P Laurent-Puig; M Muleris; R Parc; G Thomas
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

Authors:  T Iwama; Y Mishima; J Utsunomiya
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

8.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.

Authors:  R Caspari; S Olschwang; W Friedl; M Mandl; C Boisson; T Böker; A Augustin; M Kadmon; G Möslein; G Thomas
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

9.  Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.

Authors:  C Soravia; S L Sugg; T Berk; A Mitri; H Cheng; S Gallinger; Z Cohen; S L Asa; B V Bapat
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

10.  Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.

Authors:  D R Davies; J G Armstrong; N Thakker; K Horner; S P Guy; T Clancy; P Sloan; V Blair; C Dodd; T W Warnes
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more
  14 in total

1.  Germ-line and somatic mutations of the APC gene and/or ss catenin gene in the occurrence of FAP associated thyroid carcinoma.

Authors:  F Cetta; A Dhamo; G Malagnino; L Barellini
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.352

2.  Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.

Authors:  Taina T Nieminen; Christopher J Walker; Alisa Olkinuora; Luke K Genutis; Margaret O'Malley; Paul E Wakely; Lisa LaGuardia; Laura Koskenvuo; Johanna Arola; Anna H Lepistö; Pamela Brock; Ayse Selen Yilmaz; Ann-Kathrin Eisfeld; James M Church; Päivi Peltomäki; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-03       Impact factor: 6.568

3.  Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Tomonori Ohsawa; Keiichiro Ishibashi; Mineko Ushiama; Teruhiko Yoshida; Takeo Iwama
Journal:  Oncol Lett       Date:  2015-08-06       Impact factor: 2.967

Review 4.  Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View.

Authors:  Sadegh Rajabi; Catherine Alix-Panabières; Arshia Sharbatdar Alaei; Raziyeh Abooshahab; Heewa Shakib; Mohammad Reza Ashrafi
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

5.  TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.

Authors:  Eun Ji Oh; Sohee Lee; Ja Seong Bae; Yourha Kim; Sora Jeon; Chan Kwon Jung
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 6.  Familial non-medullary thyroid carcinoma: an update.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 7.  Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).

Authors:  Chiara Diquigiovanni; Elena Bonora
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

8.  Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis.

Authors:  Vania Nosé; Ozgur Mete; Baris Boyraz; Peter M Sadow; Sylvia L Asa; Dora Dias-Santagata
Journal:  Endocr Pathol       Date:  2021-05-21       Impact factor: 4.056

Review 9.  Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.

Authors:  Hong-Beom Park; Ju-Won Kim; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 10.  Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.

Authors:  Berta Luzón-Toro; Raquel María Fernández; Leticia Villalba-Benito; Ana Torroglosa; Guillermo Antiñolo; Salud Borrego
Journal:  Genes (Basel)       Date:  2019-11-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.